Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Jan;93(1-2):42-53.
doi: 10.1111/ans.18059. Epub 2022 Oct 3.

Long-term adverse effects and healthcare burden of rectal cancer radiotherapy: systematic review and meta-analysis

Alastair J Morton  1   2 , Adil Rashid  1   2 , Joanna S C Shim  1 , Joe West  1   2   3 , David J Humes  1   2 , Matthew J Grainge  1   3
Affiliations
Meta-Analysis

Long-term adverse effects and healthcare burden of rectal cancer radiotherapy: systematic review and meta-analysis

Alastair J Morton et al. ANZ J Surg. 2023 Jan.

Abstract

Background: As rectal cancer survival increases, more patients survive with potentially severe, long-term gastrointestinal and genitourinary complications from radiotherapy. The burden of these complications for patients and healthcare services is unclear, which this review aims to quantify.

Methods: Systematic search of Medline and Embase for randomized-controlled trials (RCTs) and multicentre observational studies published since 2000, reporting hospitalization/procedural intervention for long-term (>6 months post-treatment) gastrointestinal or genitourinary complications after radiotherapy and surgery for rectal cancer. Prevalence values were pooled in a meta-analysis assuming random effects. Organ-preservation patients were excluded.

Results: 4044 records screened; 24 reports from 23 studies included (15 RCTs, 8 Observational), encompassing 15 438 patients. Twenty-one studies (median follow-up 60 months) reported gastrointestinal complications post-radiotherapy: pooled prevalence 11% (95% confidence interval (95% CI) 8-14%). Thirteen reported small bowel obstruction: prevalence 9% (95% CI 6-12%), a 58% increased risk compared with surgery alone (RR 1.58, 95% CI 1.26-1.98, n = 5 studies). Seven reported fistulas: prevalence 1% (95% CI 1-2%). Thirteen reported genitourinary complications: prevalence 4% (95% CI 1-6%); RR 1.10 (95% CI 0.88-1.38, n = 3 studies) compared with surgery alone.

Conclusions: Over 10% of patients are hospitalized for long-term complications following rectal cancer radiotherapy. Serious gastrointestinal complications are commonplace; late small bowel obstruction is more common in patients having radiotherapy and surgery compared with surgery alone. Patients and clinicians need to be aware of these risks.

Keywords: complications; obstruction; radiotherapy; rectal cancer.

PubMed Disclaimer

References

    1. Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz. Gastroenterol. 2019; 14: 89-103.
    1. Brouwer NPM, Bos A, Lemmens V et al. An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients. Int. J. Cancer 2018; 143: 2758-66.
    1. Cancer Research UK. Bowel Cancer Survival Statistics. https://www.cancerresearchuk.org/health-professional/cancer-statistics/s....
    1. National Cancer Registration & Analysis Service and Cancer Research UK. Chemotherapy, Radiotherapy and Surgical Tumour Resections in England: Workbook. http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specifi....
    1. Cedermark B, Dahlberg M, Glimelius B et al. Improved survival with preoperative radiotherapy in resectable rectal cancer. N. Engl. J. Med. 1997; 336: 980-7.

LinkOut - more resources